In men, the main goal is to: Improve how cells respond to hormonal signals Indirectly support a healthier testosterone-production environment within normal limits This does not replace hormone testing when needed, but it may offer supportive help in mild to moderate cases
Peptide therapy should always be carried out under the supervision of a licensed medical professional
It might cover GLP-1 drugs when theyre prescribed for weight loss, as it wouldnt have the same statutory prohibition that applies to Part D coverage
But because GH and IGF-1 promote cell growth, they could theoretically accelerate existing cancers
Semaglutide is a GLP-1 receptor agonist that delays gastric emptying, which may contribute to burping and other upper gastrointestinal symptoms
If you currently take Wegovy or are considering starting it, review your plans 2026 formulary or contact a BCBS representative to confirm any changes to your coverage